Skip to main content
. 2017 Jul 15;66(10):1249–1264. doi: 10.1007/s00262-017-2025-8

Fig. 4.

Fig. 4

Talimogene laherparepvec proposed mechanism of action. CMV cytomegalovirus, GM-CSF granulocyte-macrophage colony-stimulating factor, hGM-CSF human GM-CSF, pA poly-adenosine, TDA tumor-derived antigen